Show simple item record

dc.contributor.authorRenehan, Andrew G
dc.contributor.authorShalet, Stephen M
dc.date.accessioned2009-07-29T11:45:34Z
dc.date.available2009-07-29T11:45:34Z
dc.date.issued2005-03-12
dc.identifier.citationDiabetes, insulin therapy, and colorectal cancer. 2005, 330 (7491):551-2 BMJen
dc.identifier.issn1468-5833
dc.identifier.pmid15760973
dc.identifier.doi10.1136/bmj.330.7491.551
dc.identifier.urihttp://hdl.handle.net/10541/75809
dc.language.isoenen
dc.subjectColorectal Canceren
dc.subject.meshColorectal Neoplasms
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshHumans
dc.subject.meshHypoglycemic Agents
dc.subject.meshInsulin
dc.subject.meshRisk Factors
dc.titleDiabetes, insulin therapy, and colorectal cancer.en
dc.typeArticleen
dc.identifier.journalBMJen


This item appears in the following Collection(s)

Show simple item record